We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Glaxo, Boehringer Ingelheim Agree to Expand Anti-HIV Licensing in South Africa

Law360 (December 10, 2003, 12:00 AM EST) -- GlaxoSmithKline and Boehringer Ingelheim agreed to allow the widespread manufacture of generic versions of their patented AIDS drugs in South Africa, according to news reports.

In an out-of-court settlement with the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.